American Well Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by American Well Corporation (AMWL) on January 8, 2025. The filing discloses the entry into a Material Definitive Agreement and the completion of the disposition of assets related to the Company's telepsychiatry business.
Key Financial Metrics and Transaction Details
- Transaction Type: Asset Purchase Agreement for the sale of the telepsychiatry business (hospitals and correctional programs).
- Upfront Consideration: $20,714,459 in cash, representing 1.1x the Business's trailing twelve-month revenue (excluding specific on-site revenue).
- Contingent Consideration: An additional payment equal to 0.4x the Buyer's aggregate revenues from the Business to current and pipeline customers over the 12 months following closing.
- Closing Date: January 8, 2025.
- Financial Statements: Pro forma financial information is referenced in Exhibit 99.1 but not detailed in the text of this filing.
Material Changes
The Company divested its telepsychiatry business segment. The transaction involved the transfer of all property, assets, contracts, accounts receivable, and accounts payable associated with the Business to Avel eCare, LLC. Additionally, Dr. Cynthia Horner transferred ownership of Asana Integrated Medical Group, an affiliated clinical partner, to a doctor affiliated with the Buyer.
Outlook, Risks, and Covenants
- Acceleration Clause: If the Buyer experiences a change-of-control event or fails to pay the Additional Payment within the specified period, the Seller may elect to receive the full 0.4x revenue amount based on the period ending prior to the event.
- Restrictive Covenants: The agreement includes a four-year non-competition covenant and a one-year non-solicitation covenant applicable to the Company and the Seller.
- Exclusions: The sale excluded cash and certain on-site revenue streams.
Investor Verification Checklist
- Review Exhibit 99.1 for Pro Forma Financial Information to assess the impact of the divestiture on future financial statements.
- Verify the definition of "on-site revenue" excluded from the trailing twelve-month revenue calculation to understand the baseline for the upfront payment.
- Monitor the Buyer's performance over the next 12 months to determine the potential value of the Additional Payment.
- Confirm the status of the transferred contracts and accounts receivable to ensure no contingent liabilities remain with the Company.